V
VIGL
Vigil Neuroscience, Inc.
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Reuters·12/02/2025 12:00
Ovid Therapeutics Names Dr. Petra Kaufmann as Chief Medical Officer
Benzinga·10/10/2025 08:27
Loss-Making Russell 2000 Stocks Drive Surprise Rally, Says Liz Ann Sonders
Reuters·08/06/2025 05:00
Sanofi Completes Acquisition of Vigil Neuroscience to Bolster Neurology Pipeline
Reuters·08/05/2025 16:30
Vigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Benzinga·08/05/2025 13:37
Vigil Neuroscience Q2 EPS $(0.56) Misses $(0.42) Estimate
TipRanks·08/05/2025 13:28
Vigil Neuroscience Inc Merger and Leadership Changes
Seeking Alpha·08/01/2025 19:00
Catalyst Watch: Palantir earnings, Firefly Aerospace IPO, OPEC+, and the Fed's SLOOS report
NASDAQ·07/31/2025 14:37
Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down
TipRanks·07/28/2025 11:57
Vigil Neuroscience Faces Stockholder Demands Post-Merger
Reuters·07/28/2025 11:15
Vigil Neuroscience Inc. Announces Merger with Sanofi; Definitive Proxy Statement Filed with SEC
Benzinga·07/25/2025 13:27
Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel
Seeking Alpha·07/19/2025 15:00
Tesla, Alphabet Set To Report Earnings As Investors Watch Out For Jobless Claims And Durable Goods Orders
Seeking Alpha·07/18/2025 21:21
Catalyst Watch: Alphabet earnings, McGraw Hill IPO, Trump talks AI, and more robotaxi buzz
TipRanks·07/17/2025 11:27
Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger
Same Industry
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.